How has been the historical performance of Dr Agarwal's Eye?

Answer:The historical performance of Dr Agarwal's Eye shows a significant upward trend in net sales and profitability over the years, culminating in the fiscal year ending March 2025. Breakdown: Dr Agarwal's Eye has demonstrated strong growth in net sales, increasing from 201.21 Cr in March 2022 to 397.15 Cr in March 2025. This growth is reflected in total operating income, which rose from 201.21 Cr in March 2022 to 397.15 Cr in March 2025. The company's total expenditure, excluding depreciation, also increased, reaching 278.65 Cr in March 2025, up from 143.53 Cr in March 2022. Operating profit (PBDIT) has shown a remarkable improvement, climbing from 57.68 Cr in March 2022 to 118.50 Cr in March 2025. Consequently, profit before tax increased from 32.31 Cr in March 2022 to 70.70 Cr in March 2025, with profit after tax following suit, rising from 24.10 Cr to 54.65 Cr in the same period. The earnings per share (EPS) also improved significantly, from 51.28 in March 2022 to 116.28 in March 2025. On the balance sheet, total assets grew from 304.27 Cr in March 2022 to 485.73 Cr in March 2024, while total liabilities increased from 145.69 Cr to 485.73 Cr during the same period. The cash flow from operating activities has also seen a positive trend, increasing from 33 Cr in March 2021 to 89 Cr in March 2024. Overall, Dr Agarwal's Eye has shown a strong financial performance with consistent growth in sales, profits, and asset base over the years.